Literature DB >> 11714935

Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract.

R Wiggins1, S J Hicks, P W Soothill, M R Millar, A P Corfield.   

Abstract

BACKGROUND: Mucinases and sialidases contribute to the process of invasion and colonisation in many conditions and infections of the female reproductive tract by degrading the protective cervical mucus. The role of hydrolytic enzymes in the pathogenesis of sexually transmitted diseases and their effect on cervical mucus are discussed in this review.
METHODS: Articles were searched for using the keywords "sialidase," "mucinase," "protease," and "sexually transmitted infections." As well as review and other articles held by our group, searches were conducted using PubMed, Grateful Med, and the University of Bath search engine, BIDS.
RESULTS: Numerous publications were found describing the production of hydrolytic enzymes in sexually transmitted diseases. Because the number of publications exceeded the restrictions imposed on the size of the review, the authors selected and discussed those which they considered of the most relevance to sexually transmitted infections.

Mesh:

Substances:

Year:  2001        PMID: 11714935      PMCID: PMC1744407          DOI: 10.1136/sti.77.6.402

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  60 in total

1.  Cell surface sialic acid and the regulation of immune cell interactions: the neuraminidase effect reconsidered.

Authors:  E U Bagriaçik; K S Miller
Journal:  Glycobiology       Date:  1999-03       Impact factor: 4.313

2.  Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour.

Authors:  L Howe; R Wiggins; P W Soothill; M R Millar; P J Horner; A P Corfield
Journal:  Int J STD AIDS       Date:  1999-07       Impact factor: 1.359

3.  MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage.

Authors:  C Wickström; J R Davies; G V Eriksen; E C Veerman; I Carlstedt
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix.

Authors:  I K Gipson; S Spurr-Michaud; R Moccia; Q Zhan; N Toribara; S B Ho; A R Gargiulo; J A Hill
Journal:  Biol Reprod       Date:  1999-01       Impact factor: 4.285

5.  Glycosidases in mucin-dwelling protozoans.

Authors:  S Connaris; P Greenwell
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

6.  Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis.

Authors:  S Cauci; S Driussi; R Monte; P Lanzafame; E Pitzus; F Quadrifoglio
Journal:  Am J Obstet Gynecol       Date:  1998-03       Impact factor: 8.661

Review 7.  Sulfomucins in the human body.

Authors:  A V Nieuw Amerongen; J G Bolscher; E Bloemena; E C Veerman
Journal:  Biol Chem       Date:  1998-01       Impact factor: 3.915

8.  Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens.

Authors:  B C Herold; A Siston; J Bremer; R Kirkpatrick; G Wilbanks; P Fugedi; C Peto; M Cooper
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

9.  Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae.

Authors:  S R Hedges; M S Mayo; L Kallman; J Mestecky; E W Hook; M W Russell
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  The ability of probiotic bacteria to bind to human intestinal mucus.

Authors:  P V Kirjavainen; A C Ouwehand; E Isolauri; S J Salminen
Journal:  FEMS Microbiol Lett       Date:  1998-10-15       Impact factor: 2.742

View more
  57 in total

1.  Cooperative regulation of the Vibrio vulnificus nan gene cluster by NanR protein, cAMP receptor protein, and N-acetylmannosamine 6-phosphate.

Authors:  Byoung Sik Kim; Jungwon Hwang; Myung Hee Kim; Sang Ho Choi
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

2.  O-linked sugars sound the alarm.

Authors:  Smita Gopinath; Yosuke Kumamoto; Akiko Iwasaki
Journal:  Nat Immunol       Date:  2016-02       Impact factor: 25.606

3.  Regulatory Characteristics of Vibrio vulnificus gbpA Gene Encoding a Mucin-binding Protein Essential for Pathogenesis.

Authors:  Kyung Ku Jang; So Yeon Gil; Jong Gyu Lim; Sang Ho Choi
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

Review 4.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Authors:  Paria Mirmonsef; Laurie Krass; Alan Landay; Gregory T Spear
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

5.  At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1.

Authors:  Jean M Macklaim; Gregory B Gloor; Kingsley C Anukam; Sarah Cribby; Gregor Reid
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

6.  Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.

Authors:  Andrea L Radtke; Alison J Quayle; Melissa M Herbst-Kralovetz
Journal:  Biol Reprod       Date:  2012-12-06       Impact factor: 4.285

7.  Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis.

Authors:  C S Bradshaw; A N Morton; S M Garland; L B Horvath; I Kuzevska; C K Fairley
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  BVBlue test for diagnosis of bacterial vaginosis.

Authors:  Linda Myziuk; Barbara Romanowski; Stephen C Johnson
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.

Authors:  Robert Bucki; Dorota B Namiot; Zbigniew Namiot; Paul B Savage; Paul A Janmey
Journal:  J Antimicrob Chemother       Date:  2008-05-01       Impact factor: 5.790

10.  Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy.

Authors:  Caroline Mitchell; Jennifer Balkus; Kathy Agnew; Richard Lawler; Jane Hitti
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.